Skip to main content
. 2021 Apr 15;144(9):2594–2609. doi: 10.1093/brain/awab155

Figure 5.

Figure 5

Tumour peptide vaccination in pHGGs. Patient-derived tumour cell lines from a tumour bank or tumour cells from surgical resection are cultured to produce tumour antigens. Tumour cells are lysed to release the tumour antigens, which are then administered to the patient to stimulate antigen-presenting cells and cytotoxic T cells to kill tumour cells.